Skip to content

royal jelly and chemotherapy

Investigating the effect of royal jelly on reducing symptoms of fatigue and weakness associated with chemotherapy in breast cancer

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231226060535N1
Enrollment
50
Registered
2023-12-29
Start date
2024-01-10
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer. Malignant neoplasm of breast

Interventions

Intervention 1: Intervention group: Each subject in the intervention group will take 1 capsule of royal jelly twice a day after meals for 4 weeks. Intervention 2: Control group: Patients in this group

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
No minimum to 60 Years

Inclusion criteria

Inclusion criteria: Confirmed diagnosis of breast cancer by laboratory and clinical evidence Hemoglobin > 8 g/dL Hematocrit > 30% SGOT serum level <3 times higher than normal Bilirubin level less than 2 mg/dl Creatinine less than 2mg/dl Normal thyroid test result

Exclusion criteria

Exclusion criteria: Having an underlying and chronic active inflammatory disease such as: RA, COPD, unstable cardiovascular disease, lung diseases such as asthma, uncontrolled pain, severe infection, pregnancy, severe depression Simultaneous use of drugs that can affect fatigue Metastatic patients with poor performance

Design outcomes

Primary

MeasureTime frame
Severity of symptoms of fatigue. Timepoint: Measurement of symptoms of fatigue before the intervention and 14 days later. Method of measurement: by Visual Analogue Scale (VAS) and Fatigue Severity Scale (FSS) questionnaires.;Severity of symptoms of weakness. Timepoint: Measurement of symptoms of weakness before the intervention and 14 days later. Method of measurement: by Visual Analogue Scale (VAS) and Fatigue Severity Scale (FSS) questionnaires.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactTahere Fallahi

Shahid Beheshti University of Medical Sciences

taherefallahi52@gmail.com+98 21 2243 9872

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026